Ctrl-0 yr | PD-0 yr | Ctrl-1 yr | PD-1 yr | Ctrl-2 yr | PD-2 yr | Ctrl-0 yr vs PD-0 yr P-value | Ctrl-1 yr vs PD-1 yr P-value | Ctrl-2 yr vs PD-2 yr P-value | |
---|---|---|---|---|---|---|---|---|---|
N | 22 | 32 | 19 | 22 | 12 | 10 | – | – | – |
Age (years)¢ | 55.59 ± 10.22 | 60.81 ± 10.23 | 54.37 ± 8.01 | 61.95 ± 11.95 | 56.42 ± 10.35 | 57.70 ± 11.04 | 0.072 | 0.027* | 0.662 |
Male: female ratio^ | 54:46 | 56:44 | 58:42 | 67:33 | 58:42 | 50:50 | – | – | – |
Body mass index¢ | 26.85 ± 3.89 | 27.52 ± 4.54 | 27.13 ± 3.62 | 27.14 ± 4.26 | 27.17 ± 4.38 | 26.87 ± 5.68 | 0.549 | 0.952 | 0.974 |
Symptom duration (years) ¢ | NA | 2 ± 1.17 | NA | 2.64 ± 1.39 | NA | 4.56 ± 1.59 | – | – | – |
Hoehn and Yahr score€ | NA | 2.00(1–3) | NA | 1.25(0–3) | NA | 2.25 (0–3) | – | – | – |
Total MDS-UPDRS¢ | 2.77 ± 4.05 | 51.59 ± 25.13 | 0.89 ± 1.85 | 39.57 ± 24.47 | 1.42 ± 2.87 | 39.90 ± 27.24 | < 0.0001* | < 0.0001* | < 0.0001* |
MDS-UPDRS I¢ | 0.72 ± 0.98 | 2.50 ± 1.60 | 0.21 ± 0.42 | 1.81 ± 1.54 | 0.50 ± 0.80 | 2.27 ± 2.21 | < 0.0001* | < 0.0001* | 0.0062 |
MDS-UPDRS II¢ | 0.32 ± 0.89 | 13.28 ± 6.56 | 0.10 ± 0.31 | 10.62 ± 6.59 | 0.50 ± 1.17 | 9.40 ± 7.49 | < 0.0001* | < 0.0001* | < 0.0001* |
MDS-UPDRS III¢ | 1.72 ± 3.71 | 35.68 ± 18.29 | 0.58 ± 1.64 | 26.05 ± 16.69 | 0.42 ± 1.16 | 24.50 ± 19.06 | < 0.0001* | < 0.0001* | < 0.0001* |
Schwab and England scale¢ | 99.54 ± 2.13 | 76.59 ± 22.55 | 100 ± 0 | 86 ± 11.42 | 100 ± 0 | 86.37 ± 12.25 | < 0.0001* | < 0.0001* | < 0.0001* |
Beck’s Depression Inventory¢ | 5.54 ± 6.24 | 11.50 ± 8.00 | 2.42 ± 3.04 | 9.43 ± 7.41 | 5.83 ± 6.63 | 11.90 ± 10.90 | 0.003* | 0.0013* | 0.108 |
Comorbidities | |||||||||
HBP | 6.67% | 33.3% | 4.54% | 45% | 8.3% | 40% | – | – | – |
T2D | 0% | 10% | 4.54% | 9% | 8.3% | 10% | – | – | – |
Hypercholesterolemia | 0% | 6.67% | 0% | 4.54% | 0% | 0% | – | – | – |
Dyslipidemia | 0% | 6.67% | 4.54% | 4.54% | 0% | 10% | – | – | – |